Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate whether treatment with targeted agents guided by high throughput molecular analyses (CGH array, next generation sequencing) improves overall progression-free survival as compared to standard maintenance therapy in patients with metastatic NSCLC.
Inclusion criteria
- Patients with metastatic non small cell lung cancer (NSCLC) in 1st line chemotherapy